company-logoBiohaven Ltd.$17.23
%
Analyst Rating: Hold

Stock Details

CEO

Vladimir Coric

Sector

Healthcare

Industry

Biotechnology

Full Time Employees

256

Address

215 Church Street, New Haven, CT, 06510

Biohaven Ltd. is a clinical-stage biopharmaceutical company. The Company focuses on development of therapies for neurological and immunoscience diseases that can change current treatment paradigms.

Top Competitors

Income Statement  

Financials

Selected Year

Revenue Estimates

EPS Estimates

Net Income Estimates

Price target for Biohaven Ltd.  $17.23

EPS

Revenue

Institutional Holder

Congress Tracker 

Insider Trading of Key Employees

Financial News: BHVN